Related Experiment Video
Updated: Sep 27, 2025

07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.5K
Placental Abruption Associated with Cerebral Palsy
1Department of Obstetrics & Gynecology, Nippon Medical School.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
|April 11, 2022
Summary
Placental abruption, the early separation of the placenta, is a significant cause of cerebral palsy. Prompt delivery is crucial if the fetus survives, as prevention methods are lacking.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Maternal-Fetal Medicine
Background:
- Placental abruption is defined as the premature separation of the placenta from the uterine wall before fetal delivery.
- It is recognized by the Japan Obstetric Compensation System for Cerebral Palsy (JOCSC) as a primary contributor to cerebral palsy.
- Placental abruption presents as either revealed or concealed hemorrhage, with concealed cases correlating to poorer maternal and infant outcomes.
Purpose of the Study:
- To highlight the importance of recognizing early symptoms of placental abruption in pregnant women.
- To underscore the lack of evidence-based preventative strategies for placental abruption.
Main Methods:
- This study is a review of existing literature and clinical guidelines regarding placental abruption.
- Analysis of data from the Japan Obstetric Compensation System for Cerebral Palsy (JOCSC) regarding the incidence and impact of placental abruption.
Main Results:
- Placental abruption is a significant risk factor for cerebral palsy.
- Concealed placental abruption is associated with more severe maternal and fetal complications.
- Immediate delivery is generally recommended when fetal survival is confirmed in cases of placental abruption.
Conclusions:
- There are currently no proven methods for preventing placental abruption.
- Increased awareness of early placental abruption symptoms among pregnant Japanese women is critical for timely intervention and improved outcomes.
Related Concept Videos
Teratogenicity
2.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K
Neurulation
42.9K
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
42.9K
Pathophysiology of Diabetes
1.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K

